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volumes and costs. Correlations and paired T-tests were used to
compare simulated annual costs with actual annual costs from
the continuous measurements. RESULTS: Analyses conﬁrmed
that discontinuous measurements using cost diaries offer good
estimates of annual health expenditures, but measurement pat-
terns and imputation methods did inﬂuence the outcomes, as the
correlations differed between methods. The best estimated
annual costs were obtained by random cohort measurement,
using three random cohorts, ensuring that at least a third of the
participants were measuring costs each month, combined with
IM imputation. Discontinuous measurement of health expendi-
tures carries a small risk of missing infrequent expensive events,
which may result in underestimation of annual costs. CONCLU-
SIONS: To reduce the burden on participants in future economic
evaluation, we recommend calculating annual costs from discon-
tinuous measurements in random cohorts, combined with IM
imputation.
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OBJECTIVES: Appropriate design and efﬁcient analytical strat-
egy are generally considered as some of the prerequisites for a
valid and reliable health outcomes research on non-randomized
observational data. For rare outcomes, the case-control design is
often presented as the most efﬁcient, whereby, proper selection of
controls is crucial. Using simulated data for the nested case-
control design, we assess the relative efﬁciencies of two sampling
strategies for the controls- the version where controls can never
be cases (design 1) and the recommended approach in which
controls are sampled from the risk sets such that some controls
can be future cases (design 2). METHODS: In each simulation,
we assumed an underlying hazard that follows a Weibull distri-
bution with inputted values for the scale and shape parameters to
generate 100 sets of cohorts of 4000 patients in treatment groups
(i.e. treated and untreated). The process also involved an
assumed hazard ratio for treatment and 3 factors that required
adjustments. Designs 1 and 2 were then applied successively on
each of the resulting datasets and then analysed to obtained for
each design, the estimated odds ratio (OR- an approximate of the
inputted hazard ratio) and its 1st and 3rd quartiles. RESULTS: We
considered over 50 scenarios for hazard ratio that varied between
0.3 and 4.0. The absolute differences between the inputted
hazard ratio and the estimated odd ratio ranged from 0.01–8.00
and from 0.01–0.50 for designs 1 and 2 respectively. The input-
ted hazard ratio was within the inter-quartile range of the OR in
less than 5% of the runs with design 1 but more than 80% with
design 2. CONCLUSIONS: Our study suggests that in nested
case-control designed studies, if controls are not sampled from
the appropriate risk sets, we can expect much larger bias in our
estimates than with correct sampling.
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OBJECTIVES: Economic analyses in health technology assess-
ment often require estimation of absolute risk difference (ARD)
for outcomes such as survival or progression, given base risk in
the jurisdiction of interest and trial evidence of treatment effects.
We demonstrate that odds ratios (OR) provide distinct advan-
tages over relative risk (RR) in consistently estimating such ARD
independent of the framing of effects (e.g. mortality or survival)
for direct and indirect comparisons. METHODS: Use of RR is
shown to lead to inferential anomalies in estimating ARD, while
consistently estimated using OR. These inferential anomalies and
odds solution are illustrated for indirect comparison of Natiluz-
imab versus Interferon beta-1b for multiple sclerosis, as well as
direct comparisons. RESULTS: Standard use of relative risk to
calculate ARD in indirect comparison suggests Natiluzimab is
more effective than Interferon for progression (RR = 0.70, ARD
= 21% for a base risk of 70% progression) but less effective than
Interferon for no progression (RR = 0.84, ARD = 4.8%). This
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inferential anomaly is avoided using OR, with odds of progres-
sion (0.83) the reciprocal of that for no progression (1.21), and
ARD of 4.1% in favor of Nataluzimab with progression or no
progression. For direct comparisons ARD is shown to be consis-
tently estimated with OR but change with framing of effects
using RR wherever epidemiological risk differs from trial risk in
the comparator arm. CONCLUSIONS: Odds ratios allow con-
sistent estimation of absolute risk differences regardless of
framing of effects in direct and indirect comparisons. This over-
comes inferential anomalies that arise with use of relative risk in
such comparisons whenever base risk differs in the jurisdiction of
interest from that in trials, or base risk in the common arms
differs in indirect comparisons. Consequently, odds ratios avoid
selection biases in framing of effects inherent with risk ratios and
are suggested as the preferred metric in estimating such risk
differences.
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OBJECTIVES: The economic literature suggests the Value of
Statistical Life (VSL) as a common measure of efﬁciency for life
saving interventions throughout different societal sectors. Policy
decisions in The Netherlands have not yet been explicitly based
on this measure, however a trade off between wealth and mor-
tality risk is made implicitly when deciding whether or not to
implement a life saving intervention. This study aimed to gain
insights into this trade off, referred to as Implicit Value of
Statistical Life (IVSL), by means of a retrospective investment
analysis of interventions implemented in The Netherlands.
METHODS: A literature search was conducted to ﬁnd life saving
intervention cases meeting the requirements for a uniform IVSL
calculation and additional inclusion criteria. A sample of 10
cases was included in the study and concerned interventions
implemented in the water control, consumer safety, transport and
health care sector. RESULTS: IVSL estimates derived from the
cases ranged from €1 to almost €11 million. Differences were
most extreme when comparing IVSL estimates of interventions
implemented in different societal sectors. However, estimates also
varied greatly between interventions in the same sector and even
within the same intervention, when critical assumptions were
altered. CONCLUSIONS: Despite limited comparability of IVSL
estimates, our ﬁndings suggest that there are great imbalances
between societal investments for preventing a statistical death.
This highlights the need to develop ways to increase transparency
and efﬁciency of policy decisions by systematically taking the
Value of Statistical Life into account. Given the conceptual prob-
lems inherent to the IVSL, future research should focus on the
potential merit of explicit VSL measures for decision making.
Since the consequences of life saving interventions are not
restricted to mortality reduction, research should also address the
question whether there is a need to incorporate broader health
and other consequences of life saving interventions in the
measure of efﬁciency.
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OBJECTIVES: There are two main approaches to questionnaire
translation for languages spoken in multiple countries called
“universal approach” and “country speciﬁc approach”. The uni-
versal approach postulates that one translation can be developed
via participation and consensus between native speaking trans-
lators from various countries where that language is spoken.
Demonstrating that the universal approach is possible for ques-
tionnaires has been the life work of neuropsychologist Dr. Lidia
Artiola Fortuny. METHODS: This poster will share the results of
a study published in the Journal of the International Neuropsy-
chological Society where participants from the US-Mexico
border region (N = 185) and Madrid, Spain (N = 205) were
compared on 16 Spanish language neuropsychological measures,
with special attention to avoid item content that was speciﬁc to
one geographic group. Differences in socio-economic, education
and health were considered. Samples were drawn from volun-
teers in each community between the ages of 18 and 76 with 0 to
20 or more years of formal education who claimed Spanish as
their ﬁrst language and demonstrated native ﬂuency in the lan-
guage. Participants were excluded from the study if they had past
neurological, emotional, psychological issues or learning difﬁcul-
ties. RESULTS: Analyses of variance were performed to study
place of birth effects on performance on each measure. Findings
indicate that the populations from Spain and the Borderland
obtained similar results for most of the measures. Participants
did not report difﬁculties with the instructions or test items.
CONCLUSIONS: Dr. Artiola Fortuny asserts that Spanish
speaking populations do not differ any more than mainstream
English speaking populations such as the United States, England
or Australia, and that one should capitalize on the great amount
of linguistic overlap across populations that share the Spanish
language.
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OBJECTIVES: In a systematic review of literature, reviewing
abstracts twice by two reviewers improves the likelihood of
correctly including relevant citations and excluding irrelevant
ones. During the second abstract review, the reviewer has had
more exposure to the literature, and thus may be more accurate
than the ﬁrst reviewer. A statistical model was ﬁtted to determine
between-reviewer and between-review reliability and variation.
METHODS: Inclusion/exclusion decisions made by two review-
ers in the abstract review stage of six recently conducted clinical
and economic systematic reviews were analysed in the context of
the ﬁnal inclusion/exclusion decision. For the ﬁrst and second
reviewers, sensitivity (the proportion of correctly included
citations) and speciﬁcity (the proportion of correctly excluded
citations) were modelled using bayesian poisson regression.
RESULTS: Across one economic and ﬁve clinical systematic
reviews, the sensitivity of reviewer one ranged from 82% to
95%; the second reviewer’s sensitivity ranged from 80% to 98%.
The speciﬁcity of reviewer one ranged from 94% to 98%;
the second reviewer’s speciﬁcity ranged from 92% to 99%. The
pattern of results varied substantially between reviews. In
the breast cancer, hyperlipidemia, and anaesthesia reviews, the
A578 Abstracts
